Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Mariah Charette

Physician Assistant Littleton, CO Physician Assistant

NPI 1730770793 CMS profile 11066491

13402 W Coal Mine Ave Ste 300, Littleton, CO 80127

Open in the dashboard

General payments

$761

66 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Mariah Charette of Littleton, CO is reported in the CMS Open Payments database as having received $761 across 66 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 63rd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $31 1
2022 General $489 48
2021 General $241 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mariah Charette
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Mariah Charette were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Mariah Charette Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $241 $132 $37–$438 $132
2022 $489 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $31 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Novo Nordisk Inc $289 21 payments
  2. AbbVie, Inc. $157 20 payments
  3. Lilly USA, LLC $119 12 payments
  4. Nestle HealthCare Nutrition Inc. $51 4 payments
  5. Exact Sciences Corporation $31 1 payment
  6. Boehringer Ingelheim Pharmaceuticals, Inc. $28 2 payments
  7. Amneal Pharmaceuticals LLC $24 1 payment
  8. Biohaven Pharmaceuticals, Inc. $15 1 payment
  9. Vanda Pharmaceuticals Inc. $13 1 payment
  10. Sanofi-Aventis U.S. LLC $12 1 payment
  11. Other $22 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $761 66 payments
Products named General payments · program years 2021–2024
  1. RYBELSUS $279 20 payments
  2. Ozempic $279 20 payments
  3. JARDIANCE $66 7 payments
  4. UBRELVY $56 7 payments
  5. TRULICITY $51 5 payments
  6. ZENPEP $51 4 payments
  7. MOUNJARO $42 4 payments
  8. QULIPTA $37 6 payments
  9. SYNTHROID $36 4 payments
  10. Cologuard Collection Kit $31 1 payment
  11. Other $139 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 48 drugs

Part D claims

1,464

Median for Physician Assistant: 241

Drug cost

$99,862

Median for Physician Assistant: $4,110

Branded share of claims

18.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Trulicity Dulaglutide Brand 12 $19,776
Ozempic Semaglutide Brand 11 $18,700
Eliquis Apixaban Brand 17 $18,208
Mounjaro Tirzepatide Brand 14 $16,667
Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 Brand 11 $7,824
Symbicort Budesonide/Formoterol Fumarate Brand 12 $5,108
Levothyroxine Sodium Generic 123 $1,013
Omeprazole Generic 33 $999
Atorvastatin Calcium Generic 142 $996
Albuterol Sulfate Hfa Albuterol Sulfate Brand 39 $747

The 10 drugs with the highest cost, of 48 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$7,414

Medicare's payments for the services billed

Medicare patients

48

Average age 70

Services billed

115

23 women, 25 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 42%
Ischemic heart disease 27%
Arthritis 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

66 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record